Protein gene product (PGP) 9.5 as a reliable marker in primitive neuroectodermal tumours--an immunohistochemical study of 21 childhood cases
- PMID: 2158936
- DOI: 10.1111/j.1365-2559.1990.tb01114.x
Protein gene product (PGP) 9.5 as a reliable marker in primitive neuroectodermal tumours--an immunohistochemical study of 21 childhood cases
Abstract
A number of antibodies to neural proteins have been used to demonstrate neuronal differentiation in primitive neuroectodermal tumours. One of them is protein gene product (PGP) 9.5, a neuronal protein isolated from brain, whose function is unknown at present. We have studied differentiation in 21 cases of primitive neuroectodermal tumours of the CNS in children. Immunocytochemical staining was performed for such neuronal markers as: PGP 9.5, neuron specific enolase and synaptophysin, a glycosylated protein associated with synaptic vesicles. Positive staining for PGP 9.5 was present in 16 cases (strong staining in 12), for neuron-specific enolase in 16 cases (strong staining in 10) and for synaptophysin in 10 cases (strong staining in six). Both PGP 9.5 and synaptophysin showed a clear staining pattern with less non-specific background than with neuron-specific enolase. Our findings demonstrate the value of using more than one antibody marker in assessing neuronal differentiation in tumours. The high incidence of positive staining with antibody to PGP 9.5 suggests that this is an essential marker in the panel of antibodies used for the identification of primitive neuroectodermal tumours.
Similar articles
-
A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children.Histopathology. 1990 May;16(5):461-7. doi: 10.1111/j.1365-2559.1990.tb01545.x. Histopathology. 1990. PMID: 2163356
-
Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.Histopathology. 2005 Apr;46(4):403-12. doi: 10.1111/j.1365-2559.2005.02101.x. Histopathology. 2005. PMID: 15810952
-
Immunohistochemical characterization of primitive neuroectodermal tumors and their possible relationship to the stepwise ontogenetic development of the central nervous system. 2. Tumor studies.Acta Neuropathol. 1991;82(6):508-15. doi: 10.1007/BF00293386. Acta Neuropathol. 1991. PMID: 1664631
-
Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.Pol J Pathol. 2007;58(1):23-33. Pol J Pathol. 2007. PMID: 17585539 Review.
-
Olfactory neuroblastoma: clinical and pathological aspects.Rhinology. 1993 Mar;31(1):1-6. Rhinology. 1993. PMID: 7686684 Review.
Cited by
-
Pleomorphic primitive neuroectodermal tumor with glial and neuronal differentiation: clinical, pathological, cultural, and chromosomal analysis of a case.J Neurooncol. 2002 Aug;59(1):71-9. doi: 10.1023/a:1016321030590. J Neurooncol. 2002. PMID: 12222841
-
A continuous cell line (KK-2) from a supratentorial primitive neuroectodermal tumor.Acta Neuropathol. 1992;84(1):52-8. doi: 10.1007/BF00427215. Acta Neuropathol. 1992. PMID: 1323907
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous